JP2007521313A5 - - Google Patents

Download PDF

Info

Publication number
JP2007521313A5
JP2007521313A5 JP2006520139A JP2006520139A JP2007521313A5 JP 2007521313 A5 JP2007521313 A5 JP 2007521313A5 JP 2006520139 A JP2006520139 A JP 2006520139A JP 2006520139 A JP2006520139 A JP 2006520139A JP 2007521313 A5 JP2007521313 A5 JP 2007521313A5
Authority
JP
Japan
Prior art keywords
phenyl
amino
compound according
methoxyphenyl
pyrrole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006520139A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007521313A (ja
Filing date
Publication date
Priority claimed from GBGB0316237.7A external-priority patent/GB0316237D0/en
Application filed filed Critical
Publication of JP2007521313A publication Critical patent/JP2007521313A/ja
Publication of JP2007521313A5 publication Critical patent/JP2007521313A5/ja
Withdrawn legal-status Critical Current

Links

JP2006520139A 2003-07-11 2004-07-08 肝臓x受容体モジュレーターとしてのピロール−2,5−ジチオン誘導体 Withdrawn JP2007521313A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0316237.7A GB0316237D0 (en) 2003-07-11 2003-07-11 Therapeutic agents
PCT/SE2004/001115 WO2005005416A1 (en) 2003-07-11 2004-07-08 Pyrrole-2, 5-dithione derivatives as liver x receptor modulators

Publications (2)

Publication Number Publication Date
JP2007521313A JP2007521313A (ja) 2007-08-02
JP2007521313A5 true JP2007521313A5 (cg-RX-API-DMAC7.html) 2007-09-13

Family

ID=27741986

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006520139A Withdrawn JP2007521313A (ja) 2003-07-11 2004-07-08 肝臓x受容体モジュレーターとしてのピロール−2,5−ジチオン誘導体

Country Status (25)

Country Link
US (1) US20060189663A1 (cg-RX-API-DMAC7.html)
EP (1) EP1646625B1 (cg-RX-API-DMAC7.html)
JP (1) JP2007521313A (cg-RX-API-DMAC7.html)
KR (1) KR20060034284A (cg-RX-API-DMAC7.html)
CN (1) CN100478340C (cg-RX-API-DMAC7.html)
AR (1) AR045720A1 (cg-RX-API-DMAC7.html)
AT (1) ATE399776T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004256000B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0412479A (cg-RX-API-DMAC7.html)
CA (1) CA2532068A1 (cg-RX-API-DMAC7.html)
CO (1) CO5640134A2 (cg-RX-API-DMAC7.html)
DE (1) DE602004014772D1 (cg-RX-API-DMAC7.html)
ES (1) ES2308205T3 (cg-RX-API-DMAC7.html)
GB (1) GB0316237D0 (cg-RX-API-DMAC7.html)
IL (1) IL172759A0 (cg-RX-API-DMAC7.html)
IS (1) IS8291A (cg-RX-API-DMAC7.html)
MX (1) MXPA06000447A (cg-RX-API-DMAC7.html)
NO (1) NO20060080L (cg-RX-API-DMAC7.html)
RU (1) RU2006102129A (cg-RX-API-DMAC7.html)
SA (1) SA04250203B1 (cg-RX-API-DMAC7.html)
TW (1) TW200507836A (cg-RX-API-DMAC7.html)
UA (1) UA82108C2 (cg-RX-API-DMAC7.html)
UY (1) UY28407A1 (cg-RX-API-DMAC7.html)
WO (1) WO2005005416A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200600229B (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0500055D0 (sv) 2005-01-10 2005-01-10 Astrazeneca Ab Therapeutic agents 3
SE0500058D0 (sv) * 2005-01-10 2005-01-10 Astrazeneca Ab Therapeutic agents 5
MX2007008370A (es) 2005-01-10 2007-08-21 Astrazeneca Ab Derivados de 1,1-dioxidos de isotiazol-3 (2h) -ona como moduladores del receptor del higado x.
ES2438739T3 (es) * 2005-06-28 2014-01-20 Daiichi Sankyo Company, Limited Procedimiento de prueba de ligando LXR
WO2008024724A1 (en) 2006-08-21 2008-02-28 Genentech, Inc. Aza-benzothiophenyl compounds and methods of use
US20100056444A1 (en) * 2006-10-12 2010-03-04 Sven Martin Jacobson Treatment of Alzheimer's Disease Using Compounds that Reduce the Activity of Non Selective Ca Activated ATP- Sensitive Cation Channels Regulated by SUR1 Receptors
US10004703B2 (en) 2006-10-12 2018-06-26 Biogen Chesapeake Llc Treatment of alzheimer's disease using compounds that reduce the activity of non-selective CA++ activated ATP-sensitive cation channels regulated by SUR1 channels
WO2008103818A1 (en) * 2007-02-21 2008-08-28 University Of Louisville Research Foundation Therapeutic cotinine compositions
CA3123813C (en) * 2007-12-04 2024-10-08 Remedy Pharmaceuticals, Inc. IMPROVED GLIBENCLAMIDE FORMULATIONS AND RELATED FREEZE-DRYING METHODS, AND FREEZE-DRY SATE PRODUCED THUS
WO2009097443A2 (en) 2008-01-29 2009-08-06 Remedy Pharmaceuticals, Inc. Liquid formulations of compounds active at sulfonylurea receptors
JP5615274B2 (ja) 2008-07-01 2014-10-29 ジェネンテック, インコーポレイテッド Mekキナーゼインヒビターとしてのイソインドロン誘導体及びその使用方法
CA2727250A1 (en) 2008-07-01 2010-01-07 Genentech, Inc. Bicyclic heterocycles as mek kinase inhibitors
CA2811145A1 (en) 2010-09-07 2012-03-15 Snu R&Db Foundation Sesterterpene compound and use thereof
AU2015204572B2 (en) 2014-01-10 2020-07-30 Inspirna, Inc. LXR agonists and uses thereof
AU2017207291B2 (en) 2016-01-11 2023-06-15 The Rockefeller University Methods for the treatment of myeloid derived suppressor cells related disorders
EP3713575A4 (en) 2017-11-21 2021-08-25 Rgenix, Inc. POLYMORPHS AND THEIR USES
KR200492570Y1 (ko) 2018-12-04 2020-11-05 박규환 조립식 계단장치를 위한 발판
JP7689964B2 (ja) 2019-12-13 2025-06-09 インスピルナ,インコーポレーテッド 金属塩及びその使用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002527419A (ja) * 1998-10-08 2002-08-27 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー Gsk−3阻害物質としてのピロール−2,5−ジオン類
EP1212065A4 (en) * 1999-07-08 2004-02-11 Tularik Inc COMPILATIONS AND METHODS FOR INCREASING THE HDL CHOLESTEROL LEVEL

Similar Documents

Publication Publication Date Title
RU2006102129A (ru) Производные пиррол-2, 5-дитиона в качестве модуляторов печеночных х-рецепторов
TWI598098B (zh) 脂質異常症治療劑
JP2022519131A5 (cg-RX-API-DMAC7.html)
JP2007508360A5 (cg-RX-API-DMAC7.html)
JP2007521312A5 (cg-RX-API-DMAC7.html)
JP2005519083A5 (cg-RX-API-DMAC7.html)
RU2003129502A (ru) Соединение, фармацевтическая композиция, применение, способ предупреждения или лечения заболеваний
RU2741306C1 (ru) Производные изоксазола в качестве агонистов ядерных рецепторов и их применение
JP2005508923A5 (cg-RX-API-DMAC7.html)
JP2007523155A5 (cg-RX-API-DMAC7.html)
JP2003520235A5 (cg-RX-API-DMAC7.html)
JP2006501295A5 (cg-RX-API-DMAC7.html)
JP2008513498A5 (cg-RX-API-DMAC7.html)
HRP20180199T1 (hr) Urea derivati ili njihove farmakološki prihvatljive soli korisni kao agonisti formil peptidnom receptoru-sličnom i (fprl-1)
JP2011505347A5 (cg-RX-API-DMAC7.html)
JP2006506466A5 (cg-RX-API-DMAC7.html)
IL322686A (en) Heterocyclic glp-1 agonists
JP2023516235A5 (cg-RX-API-DMAC7.html)
JP2007522135A5 (cg-RX-API-DMAC7.html)
JP2022543666A5 (cg-RX-API-DMAC7.html)
RU2006102130A (ru) Производные пиррол-2, 5-дитиона в качестве модуляторов печеночных х-рецепторов
JP2020111571A5 (cg-RX-API-DMAC7.html)
JP2004524279A5 (cg-RX-API-DMAC7.html)
EP2139865B1 (en) Solid forms of (e) -1- (4- ( (ir, 2s, 3r) -1, 2, 3, 4-tetrahydroxybutyl) -1h-imidazol-2-yl) ethanone oxime
JP2020534266A5 (cg-RX-API-DMAC7.html)